Detalhe da pesquisa
1.
Engineering Cancer Antigen-Specific T Cells to Overcome the Immunosuppressive Effects of TGF-ß.
J Immunol
; 208(1): 169-180, 2022 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34853077
2.
Tuning T-Cell Receptor Affinity to Optimize Clinical Risk-Benefit When Targeting Alpha-Fetoprotein-Positive Liver Cancer.
Hepatology
; 69(5): 2061-2075, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30561769
3.
Histone Deacetylase Inhibitors Enhance CD4 T Cell Susceptibility to NK Cell Killing but Reduce NK Cell Function.
PLoS Pathog
; 12(8): e1005782, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27529554
4.
Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma.
Blood
; 122(6): 863-71, 2013 Aug 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-23770775
5.
Selection, engineering, and in vivo testing of a human leukocyte antigen-independent T-cell receptor recognizing human mesothelin.
PLoS One
; 19(4): e0301175, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38574067
6.
Enhancing Efficacy of TCR-engineered CD4 + T Cells Via Coexpression of CD8α.
J Immunother
; 46(4): 132-144, 2023 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36826388
7.
Phase 1 Clinical Trial Evaluating the Safety and Anti-Tumor Activity of ADP-A2M10 SPEAR T-Cells in Patients With MAGE-A10+ Head and Neck, Melanoma, or Urothelial Tumors.
Front Oncol
; 12: 818679, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35372008
8.
Preclinical evaluation of an affinity-enhanced MAGE-A4-specific T-cell receptor for adoptive T-cell therapy.
Oncoimmunology
; 9(1): 1682381, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32002290
9.
Affinity-enhanced T-cell receptors for adoptive T-cell therapy targeting MAGE-A10: strategy for selection of an optimal candidate.
Oncoimmunology
; 8(2): e1532759, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30713784
10.
Aqueous peroxyl radical exposure to THP-1 cells causes glutathione loss followed by protein oxidation and cell death without increased caspase-3 activity.
Biochim Biophys Acta
; 1773(6): 945-53, 2007 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-17509699
11.
Common variants of apolipoprotein A-IV differ in their ability to inhibit low density lipoprotein oxidation.
Atherosclerosis
; 192(2): 266-74, 2007 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-16945374
12.
Effects of dairy products naturally enriched with cis-9,trans-11 conjugated linoleic acid on the blood lipid profile in healthy middle-aged men.
Am J Clin Nutr
; 83(4): 744-53, 2006 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-16600923
13.
NY-ESO-1-specific TCR-engineered T cells mediate sustained antigen-specific antitumor effects in myeloma.
Nat Med
; 21(8): 914-921, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26193344
14.
Examining the presentation of tumor-associated antigens on peptide-pulsed T2 cells.
Oncoimmunology
; 2(11): e26840, 2013 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24482751
15.
Identification of a Titin-derived HLA-A1-presented peptide as a cross-reactive target for engineered MAGE A3-directed T cells.
Sci Transl Med
; 5(197): 197ra103, 2013 Aug 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-23926201
16.
A moderate reduction in extracellular pH protects macrophages against apoptosis induced by oxidized low density lipoprotein.
J Lipid Res
; 49(4): 782-9, 2008 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-18202433
17.
A novel method for production of lipid hydroperoxide- or oxysterol-rich low-density lipoprotein.
Atherosclerosis
; 197(2): 579-87, 2008 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-17945239